Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pain Relief After Corneal Collagen Cross-Linking
NCT06212830Phase 1Not yet recruiting
- Sponsor
- Shamir Medical Center
- Start
- Feb 2024
- Primary completion
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of gabapentin and oxycodone in postoperative pain (3 arms), sponsored by Shamir Medical Center. Primary endpoint: Pain questionnaires at 72 hours. Planned start Feb 2024; status: not yet recruiting.
02
Drugs
gabapentinoxycodone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06212830.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06212830.